Lakefront Biotherapeutics (GXEA) Revenue

0 Followers

Lakefront Biotherapeutics Revenue

Lakefront Biotherapeutics had a revenue of 12.12M in the quarter ending Jun 30, 2026, with 86.99%. This bring the company's revenue in the last twelve months to 990.58M, Increased -5.09%. In the fiscal year ending Dec 31, 2025, Lakefront Biotherapeutics had annual revenue of 1.11B with 303.50% growth.

Revenue (ttm)

990.58M

Revenue Growth

259.41%

P/S Ratio

1.38

Revenue/Employee

€2,460,726

Employees

452

Market Cap

€1.54B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.11B	836.60M	+303.50%
Dec 31, 2024	275.65M	35.92M	+14.99%
Dec 31, 2023	239.72M	-1.52M	-0.63%
Dec 31, 2022	241.25M	-243.60M	-50.24%
Dec 31, 2021	484.85M	6.79M	+1.42%
Dec 31, 2020	478.05M	-356.85M	-42.74%
Dec 31, 2019	834.90M	546.07M	+189.06%
Dec 31, 2018	288.84M	161.75M	+127.27%
Dec 31, 2017	127.09M	―	―